Defibrillator Market to be Worth $22.76 Billion by 2031
Meticulous Research®—a
leading market research company, published a research report titled, 'Defibrillator
Market by Product (Implantable (ICD) [Transvenous {Dual Chamber,
Single-chamber, CRT-D}, Subcutaneous], External (ECD) [Manual, Automated,
Wearable]), End User (Hospital, Emergency Care, Home Care), Age Group – Global
Forecast to 2031.’
According to this
latest publication from Meticulous Research®, the defibrillator
market is projected to reach $22.76
billion by 2031, at a CAGR of 6.9% from 2024 to 2031. The growth of the
defibrillator market is driven by several factors, including the increasing
burden of cardiovascular diseases and the rise in obesity incidence, the
adoption of a sedentary lifestyle, and excessive consumption of alcohol &
caffeinated products, technological advancements in defibrillator devices and
the rising geriatric population. However, the lack of skilled professionals and
the increase in reported cases of defibrillator malfunctions & product recalls
restrains market growth.
The high incidence of
clinical adverse events attributed especially to high-risk medical devices has
led to an advocated change from many stakeholders. This is especially true with
respect to devices like cardiac implants, with their high-risk nature and high
complication rates associated with considerable mortality due to their frequent
use in older populations with frequent co-morbidities. For instance, in July
2023, Medtronic plc (Ireland) recalled their Implantable Cardioverter
Defibrillators (ICDs) Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)
with glassed feedthrough for risk of low or no energy output during high
voltage therapy. The reason for this recall was the failure of the devices to
deliver low or no energy output, which can fail to correct arrhythmias, leading
to cardiac arrest, other serious injuries, or death.
Key Players
The key players
profiled in the defibrillator market report are Medtronic plc (Ireland), Boston
Scientific Corporation (U.S.), Abbott Laboratories (U.S.), Biotronik Se &
Co., Kg (Germany), LivaNova plc (U.K.), Stryker Corporation (U.S.), Koninklijke
Philips N.V. (Netherlands), Nihon Kohden Corporation (Japan), Progetti Srl
(Italy), Fukuda Denshi Co., Ltd. (Japan), Schiller AG (Switzerland), and ZOLL
Medical Corporation (U.S.).
The defibrillator
market is segmented by Product (Implantable Cardioverter Defibrillators
[Transvenous Implantable Cardioverter Defibrillators {Cardiac Resynchronization
Therapy Defibrillators (CRT-D), Dual-Chamber Implantable Cardioverter
Defibrillators, Single-chamber Implantable Cardioverter Defibrillators},
Subcutaneous Implantable Cardioverter Defibrillators], External Cardiac
Defibrillators [Manual ECD, Automated ECD {Semi-automated ECD, Fully-automated
ECD}, Wearable ECD), Age Group (Adult, Children), End User (Hospital and
Ambulatory Surgery Centers, Pre Hospital/Emergency Care, Public Access
Programs, Alternative/Foster Care, and Homecare), and Geography. The study also
evaluates industry competitors and analyzes the regional and country-level markets.
Among products, in 2024, the implantable cardioverter
defibrillators segment is expected to account for the largest share of the
market. The large share of the segment is attributed to the rising adoption of
permanent implantable cardioverter defibrillators for the prevention of sudden
cardiac arrest and related deaths in patients at high risk of it. Technological
developments leading to the development of advanced defibrillators are
supporting the largest market share. For instance, in March 2022, Rapid
Response Revival Research Ltd (U.K.) launched CellAED, which is a personal
defibrillator, which is a handheld device that improves the chances of
surviving a sudden cardiac arrest. This device is portable and easy to use and
does not require any special medical training.
Among age groups, in 2024, the adult segment is expected to
account for the larger share of the market. Defibrillators are used to regulate
irregular heartbeats or revive the heart in case of a sudden cardiac arrest.
Increasing incidence of obesity, sedentary workstyle, and excessive consumption
of alcohol and caffeinated products increases the risk of cardiac arrests,
particularly in the adult population, as these risk factors are more prevalent
in adults than children. For instance, as per data updated by the Sudden Cardiac
Arrest Foundation (U.S.), in the U.S., the annual incidence of out-of-hospital
cardiac arrests (OHCA) reported is 347,322 in adults, compared to 7,037 in
children. Thus, the demand for defibrillators is higher in adults compared to
children.
Among end users, in 2024, the hospitals segment is
expected to account for the largest share of the market. Being one of the most
conventional and highly preferred healthcare settings with wide presence, easy
accessibility, and better healthcare infrastructure, most of the patients
initially visit hospitals for any healthcare concerns. The large share of the
market is attributed to factors such as the large pool of patients with
cardiovascular diseases visiting the hospitals for diagnosis & treatment of
cardiac diseases, easy accessibility, and better healthcare facilities in
hospitals as compared to other healthcare institutions.
Among geographies, in 2024, North America is expected to
account for the largest share of the market. The U.S. is the largest
share-holding country in North America. The large share of this region is
attributed to factors such as increasing incidence of cardiovascular diseases
among the rising geriatric population, increasing burden of hypertension;
well-established healthcare system & distribution channel; higher spending
on healthcare; and presence of leading players in this region. For instance,
according to the Centers for Medicare & Medicaid Services (CMS), the U.S.
healthcare expenditure was $4.5 trillion in 2022 as compared to $4.3 trillion
in 2021. Along with this, the increasing number of chronic diseases, the
presence of large medical device manufacturers in this region, and increased
accessibility & higher adoption of technically advanced medical devices are
driving the growth of defibrillator devices in the country.
Download Sample
Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=3596
Key questions
answered in the report:
- Which are the high-growth market segments
in terms of defibrillators by product, age group, end user, and geography?
- What was the historical market for
defibrillators across the globe?
- What are the market forecasts and
estimates for the period 2024–2031?
- What are the major drivers, restraints,
opportunities, and challenges in the defibrillator market?
- Who are the major players operating in the
defibrillator market?
- What is the competitive landscape like,
and who are the leaders in the defibrillator market?
- What are the recent developments in the
defibrillator market?
- What are the different strategies adopted
by the major players in the defibrillator market?
- What are the geographical trends and
high-growth regions/countries?
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment